Affymetrix Inc. and PathWork Informatics Inc. have announced that Affymetrix has granted PathWork long-term non-exclusive access to its microarray technology to develop and market in-vitro diagnostic ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pathwork Diagnostics, Inc., a pioneer in creating genomics-based diagnostics in oncology utilizing their proprietary informatics platform, today announced the ...

SUNNYVALE, Calif., July 31 /PRNewswire/ -- Pathwork Diagnostics, Inc., a molecular diagnostics company focused on oncology, today announced that the U.S. Food and Drug Administration (FDA) has cleared ...

SAN FRANCISCO, Oct. 20, 2025 /PRNewswire/ -- Pathwork, the AI-native platform modernizing the $160 billion life and health insurance market, today announced a strategic partnership with AIMCOR Group, ...

Pathwork Diagnostics Inc., has announced that it has entered into a research collaboration with Novartis. The parties intend to discover clinically meaningful biomarker signatures that can serve as ...

Federal regulators said Thursday that they have given Pathwork Diagnostics of Sunnyvale permission to begin selling a new genetic test to determine what type of cancer cells are in a malignant tumor.

SAN FRANCISCO, Sept. 9, 2025 /PRNewswire/ -- Pathwork, an autonomous distribution platform modernizing the $160 billion life and health insurance market, has raised a $3.5 million seed round led by ...

Pathwork Diagnostics, a Sunnyvale, Calif.-based maker of cancer diagnostic tets, has raised $20 million in a second round of funding. The round was led by new investor Abingworth Management, with ...

Are you or someone you care about wondering if therapy might be helpful? Maybe you've thought, "I don't want to feel like this anymore, but I don't know what to do," or "Something just doesn’t feel ...